Literature DB >> 597472

In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytes.

W S Ng, M H Ng, H C Ho, J P Lamelin.   

Abstract

Peripheral leucocytes from nasopharyngeal carcinoma (NPC) patients and control subjects, which included healthy subjects and patients with other cancers, have been tested against PPD and a panel of extracts from Raji cells and pooled NPC biopsies, using the blast transformation and the macrophage migration inhibition assays. The results of both assays indicated that the in vitro cell-mediated immune (CMI) responses to the Raji-cell extracts and NPC-biopsy extracts were associated with NPC. However, the peripheral leucocytes from NPC patients and control subjects responded similarly to PPD. These results are in general accord with the skin tests reported by Levine et al. (1976) and Ho, Ng and Kwan (1977b). The antigenic specificity of the NPC-associated CMI responses remains, however, to be resolved, as the extracts used in these or in the in vivo CMI studies were heterogeneous mixtures.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 597472      PMCID: PMC2025569          DOI: 10.1038/bjc.1977.254

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  EB viral genomes in epithelial nasopharyngeal carcinoma cells.

Authors:  H Wolf; H zur Hausen; V Becker
Journal:  Nat New Biol       Date:  1973-08-22

2.  Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.

Authors:  J G Derge; L M Martos; M A Tagamets; S Y Chang; M Chakrabarty
Journal:  Nat New Biol       Date:  1973-08-15

3.  Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.

Authors:  G Henle; W Henle; G Klein
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

4.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

5.  Study on the surface polypeptides isolated from human lymphoblastoid ce-ls by ionic shock.

Authors:  E H Lo; M H Ng; W S Ng; S Lui; H C Ho
Journal:  Biochim Biophys Acta       Date:  1976-10-22

6.  Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.

Authors:  D P Huang; J H Ho; W Henle; G Henle
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

7.  Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

Authors:  G Klein; B C Giovanella; T Lindahl; P J Fialkow; S Singh; J S Stehlin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens.

Authors:  F Nkrumah; W Henle; G Henle; R Herberman; V Perkins; R Depue
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

9.  IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.

Authors:  H C Ho; M H Ng; H C Kwan
Journal:  Br J Cancer       Date:  1977-06       Impact factor: 7.640

10.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.

Authors:  H C Ho; M H Ng; H C Kwan; J C Chau
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640

View more
  3 in total

1.  Antigenic content of an in vitro cellular immunity reactive cell surface extract of Raji cells.

Authors:  M H Ng; W S Ng; H C Ho
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

2.  A study of Epstein Barr virus receptor activity in cell free extracts of human lymphoblastoid cells.

Authors:  M H Ng; S W Lui; K H Chan
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Glycoproteins and sialyl transferase of human B lymphoblastoid cell lines.

Authors:  S W Lui; M H Ng
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.